Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 2-Fluoroaniline | HCID 9584 | — |
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 6-Chloro-8-((4-methoxybenzyl)(phenyl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid | HCID 59624883 | — |
| Reactant | HCID 178511674 | HCID 178511674 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Water methylene chloride | HCID 21908982 | — |
| Product | 6-((trans)-2-Aminocyclohexylamino)-n-(2-fluorophenyl)-8-(phenylamino)imidazo[1,2-b]pyridazine-3-carboxamide | HCID 68762287 | — |
| Product | HCID 178511620 | HCID 178511620 | 65.3% |
Reaction Steps
In a 2 dram reaction vial containing acetonitrile (1 mL) at room temperature was added 6-chloro-8-((4-methoxybenzyl)(phenyl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid (0.025 g, 0.06 mmol), 2-fluoroaniline (0.010 g, 0.09 mmol), EDCI (0.018 g, 0.09 mmol), HOBt (0.012 g, 0.09 mmol), and triethylamine (0.025 mL, 0.18 mmol). The suspension was stirred overnight at room temperature. The reaction mixture was then concentrated in vacuo and the residue mixed with trans-1,4-diaminocyclohexane (0.5 g, 4.39 mmol) and heated to 160° C. for 5 h. After cooling to room temperature, the reaction mixture was diluted with DCM/water and the layers were separated. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was dissolved in DCM (1 mL) at room temperature and charged with TFA (1 mL). The mixture was stirred 3 h, whereupon the volatiles were removed via a stream of nitrogen and the crude mixture was purified via preparative HPLC (Waters Sunfire column 5u, 100 A°, 19×100 mm, 20-100% Solvent B, (Solvent A (90% water, 10% methanol, 0.1% TFA), Solvent B (10% water, 90% methanol, 0.1% TFA), 10 min gradient, 10 minute run, 25 mL/min)), affording the title compound, 6-((trans)-4-aminocyclohexylamino)-N-(2-fluorophenyl)-8-(phenylamino)imidazo[1,2-b]pyridazine-3-carboxamide (0.009 g, 22%). HPLC: Rt=3.12 min. (Waters sunfire 4.6×50 mm C18.5 um 4 min/1 min hold time 0-100% (A-B) A=10% MeOH-90% water-0.1% TFA, B=90% MeOH-10% water-0.1% TFA). MS: [M+H]=460.0.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08389527B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-b0194017958b4096b3ded359903b8961 |
|---|
| Source note | uspto-grants-2013_03 |
|---|